FDA warns on safety threat posed by 2 drugs initially backed by Trump for Covid-19 — following an emergency use authorization
Two of President Trump’s initial top picks as near-term therapeutic remedies for Covid-19 are the subject of an FDA safety warning today.
The agency issued …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
